Recurring chromosomal REs, such as breakage–fusion–bridge cycles, can produce focal FGFR2 amplifications (FGFR2amp)16,17,24, which we observed in a fraction of tumours with FGFR2 REs (Extended Data Fig. 1g). The gene discussed is FGFR2; the disease is neoplasm.